5α-dihydrotestosterone reduces renal Cyp24a1 expression via suppression of progesterone receptor

    1. Eui-Ju Hong1
    1. 1College of Veterinary Medicine, Chungnam National University, Daejeon, Republic of Korea
    2. 2Korean Institute of Oriental Medicine, Daejeon, Republic of Korea
    3. 3College of Veterinary Medicine, Kangwon National University, Chuncheon, Gangwon, Republic of Korea
    4. 4Department of Biomaterials Science, College of Natural Resources & Life Science, Pusan National University, Miryang, Republic of Korea
    5. 5College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk, Republic of Korea
    1. Correspondence should be addressed to E-J Hong: ejhong{at}cnu.ac.kr

    Abstract

    Androgens act in concert with vitamin D to influence reabsorption of calcium. However, it is unclear whether androgens directly regulate vitamin D homeostasis or control other cellular events that are related to vitamin D metabolism. To examine whether the expression of vitamin D-related genes in mouse kidney is driven by androgens or androgen-dependent effects, the androgen receptor and other sex steroid receptors were monitored in orchidectomized mice treated with 5α-dihydrotestosterone (DHT). Our results revealed that exposing orchidectomized mice to DHT inhibited the expression of progesterone receptor (Pgr) with or without estrogen receptor α expression, the latter was confirmed by ER-positive (MCF7 and T47D) or -negative (PCT) cells analysis. The loss of Pgr in turn decreased the expression of renal 24-hydroxylase via transcriptional regulation because Cyp24a1 gene has a progesterone receptor-binding site on promoter. When male kidneys preferentially hydroxylate 25-hydroxyvitamin D3 using 24-hydroxylase rather than 25-hydroxyvitamin D3-1-alpha hydroxylase, DHT suppressed the Pgr-mediated 24-hydroxylase expression, and it is important to note that DHT increased the blood 25-hydroxyvitamin D3 levels. These findings uncover an important link between androgens and vitamin D homeostasis and suggest that therapeutic modulation of Pgr may be used to treat vitamin D deficiency and related disorders.

    Keywords
    • Received 10 December 2017
    • Accepted 22 December 2017
    | Table of Contents